Porton Pharma Solutions

Chongqing, China
Small Molecule API Peptides & Oligos Finished Dosage Forms ADC / Bioconjugation Cell & Gene Therapy
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP ✓ HC GMP (2)

Quick Facts: Porton Pharma Solutions

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Chongqing, China
Website
Modalities
Small Molecule API, Peptides & Oligos, Finished Dosage Forms, ADC / Bioconjugation, Cell & Gene Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Porton Pharma Solutions

Porton Pharma Solutions is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API, Peptides & Oligos, Finished Dosage Forms, ADC / Bioconjugation, Cell & Gene Therapy. 2 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.portonpharma.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Porton Pharma Solutions FDA Inspection History

2024-03
NAI VAI OAI
Date Site Type Observations Classification
2024-03-29
Porton Pharma Solutions Ltd
Changshou, Chongqing Company-level
Drug Quality Assurance No No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Porton Pharma Solutions

How many FDA inspections does Porton Pharma Solutions have on record?
CDMO Signal tracks 1 FDA inspection for Porton Pharma Solutions, sourced from the FDA inspection database. See the full inspection history above.
Has Porton Pharma Solutions received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Porton Pharma Solutions.
Does Porton Pharma Solutions have a CDMO Signal Score?
Not yet. Porton Pharma Solutions is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Porton Pharma Solutions for a manufacturing program?
Use the free AI matchmaker to compare Porton Pharma Solutions against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
ADC / Bioconjugation CDMOs → Cell & Gene Therapy CDMOs →

Similar CDMOs

Cohance Lifesciences
India
Small Molecule API, ADC / Bioconjugation, Peptides & Oligos
Asymchem Laboratories (Tianjin)
China
Small Molecule API, Peptides & Oligos
Changzhou SynTheAll Pharmaceutical (WuXi STA)
China
Small Molecule API, Peptides & Oligos
ChemExpress
Shanghai, China
Small Molecule API, Intermediates, High-Potency APIs, ADC / Bioconjugation, Peptides, Oligonucleotide
Huateng Pharma
Changsha, Hunan, China
ADC / Bioconjugation, Lipids, Intermediates, Small Molecule API, Custom Synthesis

Compare Porton Pharma Solutions with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Porton Pharma Solutions
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.